Clinical Trial Update: Impact of a Melatonin Supplementation on the Quality of Life in Elderly Metastatic Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating melatonin supplementation for quality of life in elderly patients with metastatic cancer; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Centre Jean Perrin | Conditions: Cancer | Phase 3 | Status: TERMINATED